Liver regeneration as treatment target for severe alcoholic hepatitis

Znanstveni rad - Pregledni rad

• Autor: Lucija Virović-Jukić
• Autor: Dominik Ljubas
• Autor: Sanja Stojsavljević-Shapeski
• Autor: Neven Ljubičić
• Autor: Tajana Filipec Kanižaj
• Autor: Ivana Mikolašević
• Autor: Ivica Grgurević
• Autorova ustanova: Sveučilište u Zagrebu; Medicinski fakultet; (KATEDRA ZA INTERNU MEDICINU)
• Znanstveno / umjetničko područje, polje i grana: BIOMEDICINA I ZDRAVSTVO; Kliničke medicinske znanosti; Interna medicina

Sažetak (engleski)

Severe alcoholic hepatitis (AH) is a distinct entity in the spectrum of alcohol-related liver disease, with limited treatment options and high mortality. Supportive medical care with corticosteroids in selected patients is the only currently available treatment option, often with poor outcomes. Based on the insights into the pathogenetic mechanisms of AH, which are mostly obtained from animal studies, several new treatment options are being explored. Studies have implicated impaired and deranged liver regeneration processes as one of the culprit mechanisms and a potential therapeutic target. Acknowledging evidence for the beneficial effects of granulocyte colony-stimulating factor (G-CSF) on liver regeneration and immunomodulation in animal models, several human studies investigated its role in the treatment of advanced alcohol-related liver disease and AH. Contrary to the previously published studies suggesting benefits of G-CSF in the outcomes of patients with severe AH, these effects were not confirmed by a recently published multicenter randomized trial, suggesting that other options should rather be pursued. Stem cell transplantation represents another option for improving liver regeneration, but evidence for its efficacy in patients with severe AH and advanced alcohol-related liver disease is still very scarce and unconvincing, with established lack of efficacy in patients with compensated cirrhosis. In this review, we summarize the current knowledge on the pathogenesis and experimental therapies targeting liver regeneration. The lack of high-quality studies and evidence is a major obstacle in further treatment development. New insights into the pathogenesis of not only liver injury, but also liver regeneration processes are mandatory for the development of new treatment options. A reliable experimental model of the pathogenesis of AH and processes involved in liver recovery is still missing, and data obtained from animal studies are essential for future research.

• Ključne riječi (engleski): Adrenal Cortex Hormones / therapeutic use; Animals; Focal Nodular Hyperplasia; Granulocyte Colony-Stimulating Factor / therapeutic use; Hepatitis, Alcoholic / drug therapy; Humans; Liver Diseases / drug therapy; Liver Regeneration
• Jezik: engleski
• Vrsta publikacije: Znanstveni rad - Pregledni rad
• Status objave: Objavljen
• Vrsta recenzije: Recenziran
• Verzija publikacije: Objavljena verzija rada (izdavačev PDF)
• Naslov časopisa: World Journal of Gastroenterology
• Brojčani podaci: vol. 28, br. 32, str. 4557-4573
• p-ISSN: 1007-9327
• e-ISSN: 2219-2840
• DOI: https://doi.org/10.3748/wjg.v28.i32.4557
• URN:NBN: urn:nbn:hr:105:934140
• Datum objave publikacije: 2022-08-28
• URL dokumenta: https://www.wjgnet.com/1007-9327/full/v28/i32/4557.htm
• Vrsta resursa: Tekst
• Prava pristupa: Otvoreni pristup
• Datum i vrijeme pohrane: 2023-01-26 07:56:56